Suning Chen
The First Affiliated Hospital of Soochow University · The First Affiliated Hospital of Soochow University Principal Investigator · First Affiliated Hospital of Suzhou Medical College
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Suning Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:44 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07635485 · VA Induction and Bridging Transplantation for Hypoplastic/Secondary AMLThe First Affiliated Hospital of Soochow University · not yet recruiting · Hypoplastic Acute Myeloid Leukemia, Secondary AML (Adult) · principal investigator
- Ph2NCT07573670 · A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow University · not yet recruiting · Newly Diagnosed Mixed Phenotype Acute Leukemia · principal investigator
- Ph2NCT07564453 · Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic LeukemiaThe First Affiliated Hospital of Soochow University · recruiting · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · principal investigator
- Ph1NCT07270770 · BY002 IIT Study in R/R Acute LeukemiaThe First Affiliated Hospital of Soochow University · recruiting · Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia · principal investigator
- Ph3NCT06051409 · A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)Ascentage Pharma Group Inc. · recruiting · Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive · principal investigator
- N/ANCT06013683 · A Registry for Patients With Systemic Mastocytosis in ChinaThe First Affiliated Hospital of Soochow University · unknown · Systemic Mastocytoses · principal investigator
- Ph2NCT05821738 · Avapritinib in CBF-AML With KIT MutationsThe First Affiliated Hospital of Soochow University · unknown · Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors · principal investigator
- Ph3NCT05707832 · A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusCSPC Ouyi Pharmaceutical Co., Ltd. · completed · Invasive Candidiasis, Invasive Aspergillosis · principal investigator
- Ph2NCT05557110 · Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALLChen Suning · completed · B Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT05521204 · Olverembatinib for FGFR1-rearranged NeoplasmsThe First Affiliated Hospital of Soochow University · recruiting · Myeloproliferative Neoplasm, Acute Leukemia · principal investigator
- N/ANCT05504408 · Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid LeukemiaThe First Affiliated Hospital of Soochow University · unknown · Systemic Mastocytosis With AHNMD, Acute Myeloid Leukemia With T(8;21)(Q22;Q22) · principal investigator
- Ph2/Ph3NCT05404906 · AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First RemissionThe First Affiliated Hospital of Soochow University · recruiting · Acute Myeloid Leukemia (AML) in Remission · principal investigator
- Ph2NCT05282719 · Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in AdultsThe First Affiliated Hospital of Soochow University · unknown · Myelodysplastic/Myeloproliferative Neoplasms, Adult · principal investigator
- Ph3NCT05149365 · Sitagliptin for Prevention of aGVHD After Alternative Donor TransplationThe First Affiliated Hospital of Soochow University · completed · Acute-graft-versus-host Disease, Allogeneic Hematopoietic Stem Cell Transplantation · principal investigator
- N/ANCT05123352 · Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction TherapiesThe First Affiliated Hospital of Soochow University · unknown · Acute Myeloid Leukemia, Adult, Gut Microbiota · principal investigator
- Early Ph1NCT04439721 · γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue RelapsePersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · Leukemia, B-cell · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 11:44 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- 326 citationsRCR 11.5
- Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.Leukemia · 201074 citationsRCR 1.8
- Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.Haematologica · 201171 citationsRCR 1.4
- 52 citationsRCR 1.9
- Efficacy of intracellular immune checkpoint-silenced DC vaccine.JCI Insight · 201836 citationsRCR 1.2
- The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients.Sci Rep · 202233 citationsRCR 2.0
- 29 citationsRCR 1.3
- Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemia: results of the Malaysia-Singapore Leukemia Study Group.J Pediatr Hematol Oncol · 200723 citationsRCR 0.6
- Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation.Pediatr Blood Cancer · 201720 citationsRCR 0.6
- Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia.Pediatr Blood Cancer · 201820 citationsRCR 0.6